• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV inf

tetano

Editor, Senior Moderator
Clin Immunol. 2020 Apr 21:108440. doi: 10.1016/j.clim.2020.108440. [Epub ahead of print]
Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children.


Cotugno N[SUP]1[/SUP], Zicari S[SUP]1[/SUP], Morrocchi E[SUP]2[/SUP], de Armas LR[SUP]3[/SUP], Pallikkuth S[SUP]3[/SUP], Rinaldi S[SUP]4[/SUP], Ruggiero A[SUP]1[/SUP], Manno E[SUP]1[/SUP], Zangari P[SUP]1[/SUP], Chiriaco M[SUP]1[/SUP], Bernardi S[SUP]1[/SUP], Andrews SF[SUP]5[/SUP], Cagigi A[SUP]5[/SUP], Rossi P[SUP]1[/SUP], McDermott AB[SUP]5[/SUP], Pahwa S[SUP]3[/SUP], Palma P[SUP]6[/SUP].

Author information




Abstract

Perinatally HIV-infected children (PHIV), despite successful antiretroviral therapy, present suboptimal responses to vaccinations compared to healthy-controls (HC). Here we investigated phenotypic and transcriptional signatures of H1N1-specific B-cells (H1N1-Sp) in PHIV, differentially responding to trivalent-influenza-vaccine (TIV), and HC. Patients were categorized in responders (R) and non-responders (NR) according to hemagglutination-inhibition-assay at baseline and 21 days after TIV. No differences in H1N1-Sp frequencies were found between groups. H1N1-Sp transcriptional analysis revealed a distinct signature between PHIV and HC. NR presented higher PIK3C2B and NOD2 expression compared to R, confirmed by downregulation of PIK3C2B in resting-memory of R after H1N1 in-vitro stimulation. In conclusion this study confirms that qualitative rather than quantitative analyses are needed to characterize immune responses in PHIV. These results further suggest that higher PIK3C2B in H1N1-Sp of NR is associated with lower H1N1 immunogenicity and may be targeted by future modulating strategies to improve TIV responses in PHIV.
Copyright ? 2020. Published by Elsevier Inc.



KEYWORDS:

Antigen specific B cells; Gene expression; H1N1; Influenza vaccination; PIK3C2B; Perinatally HIV infected children


PMID:32330555DOI:10.1016/j.clim.2020.108440
 
Back
Top Bottom